However, another research has found that NSCLC-derived IL-18 stimulates anti-tumor IFN-γ production from a minor part of CD8+ T cells (T-bet+Eomes+) that expresses a high level of IL-18R [209]. The gene discussed is CD8A; the disease is neoplasm.